These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 11821796
1. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T. Surgery; 2002 Jan; 131(1 Suppl):S109-13. PubMed ID: 11821796 [Abstract] [Full Text] [Related]
2. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Renehan A, O'Dwyer ST, Haboubi N, Kumar S. Br J Cancer; 2003 May 06; 88(9):1424-31. PubMed ID: 12778073 [Abstract] [Full Text] [Related]
3. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H. Clin Cancer Res; 2001 Nov 06; 7(11):3410-5. PubMed ID: 11705856 [Abstract] [Full Text] [Related]
4. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G. Oral Oncol; 2005 Feb 06; 41(2):147-55. PubMed ID: 15695116 [Abstract] [Full Text] [Related]
5. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A, Czekierdowska S, Czuba B, Cnota W, Sodowski K, Kotarski J, Zwirska-Korczala K. J Physiol Pharmacol; 2008 Sep 06; 59 Suppl 4():45-51. PubMed ID: 18955753 [Abstract] [Full Text] [Related]
6. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G. Br J Haematol; 2002 Sep 06; 118(3):817-20. PubMed ID: 12181051 [Abstract] [Full Text] [Related]
7. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105. Kumagai Y, Sobajima J, Higashi M, Ishiguro T, Fukuchi M, Ishibashi K, Baba H, Mochiki E, Yakabi K, Kawano T, Tamaru J, Ishida H. Jpn J Clin Oncol; 2014 Jun 06; 44(6):526-33. PubMed ID: 24748644 [Abstract] [Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S. Hum Pathol; 2006 Jul 06; 37(7):861-6. PubMed ID: 16784986 [Abstract] [Full Text] [Related]
9. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA. APMIS; 2003 Nov 06; 111(11):1011-8. PubMed ID: 14629267 [Abstract] [Full Text] [Related]
10. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Yao Y, Kubota T, Takeuchi H, Sato K. Neuropathology; 2005 Sep 06; 25(3):201-6. PubMed ID: 16193836 [Abstract] [Full Text] [Related]
11. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V, Cerasoli S, Vitarelli E, Tuccari G. Acta Neuropathol; 2007 Aug 06; 114(2):147-56. PubMed ID: 17594108 [Abstract] [Full Text] [Related]
13. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer. Goldiş DS, Sferdian MF, Tarţă C, Fulger LO, Totolici BD, Neamţu C. Rom J Morphol Embryol; 2015 Aug 06; 56(2):419-24. PubMed ID: 26193208 [Abstract] [Full Text] [Related]
14. Interaction between morphology and angiogenesis in human early colorectal cancers. Okada K, Satoh T, Fujimoto K, Tokunaga O. Pathol Int; 2004 Jul 06; 54(7):490-7. PubMed ID: 15189502 [Abstract] [Full Text] [Related]
16. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H. Prostate; 2015 Jan 06; 75(1):84-91. PubMed ID: 25307287 [Abstract] [Full Text] [Related]
17. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N. Cancer Res; 1999 Feb 15; 59(4):856-61. PubMed ID: 10029075 [Abstract] [Full Text] [Related]
18. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y, Pan Y, Chen J, Sun X, Qiu Y, Ding Y. Ann Clin Lab Sci; 2007 Feb 15; 37(1):39-48. PubMed ID: 17311868 [Abstract] [Full Text] [Related]
19. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. Yu JX, Zhang XT, Liao YQ, Zhang QY, Chen H, Lin M, Kumar S. World J Gastroenterol; 2003 Dec 15; 9(12):2866-9. PubMed ID: 14669355 [Abstract] [Full Text] [Related]
20. Comparison of blood neoangiogenesis and lymphatic vascularization in colorectal adenomas from patients with and without concomitant colorectal cancer. Moreira LR, Schenka AA, Filho PL, Lima CS, Trevisan MA, Vassallo J. Braz J Med Biol Res; 2009 Jul 15; 42(7):593-8. PubMed ID: 19466284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]